Showing results (471-480 of 744) with videos related to

Sort By:
Pageof 75
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practiceOwen A O'Connor, Govind Bhagat, Karthik Ganapathi, et al.
Seminars in Cancer Biology|May 13, 2025
HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injuryKenneth K W To, Seda S Tolu, Longling Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 14, 2012
Drug resistance: still a daunting challenge to the successful treatment of AMLBrian C Shaffer, Jean-Pierre Gillet, Chirayu Patel, et al.
Epilepsia|September 15, 2022
Identification of patients with drug-resistant epilepsy in electronic medical record data using the Observational Medical Outcomes Partnership Common Data ModelVictor G Castano, Matthew Spotnitz, Genna J Waldman, et al.
Preventive Medicine|July 21, 2015
Dipstick proteinuria as a predictor of all-cause and cardiovascular disease mortality in Bangladesh: A prospective cohort studyGene R Pesola, Maria Argos, Yu Chen, et al.
American Journal of Obstetrics and Gynecology|May 21, 2019
Use of fertility preservation services in female reproductive-aged cancer patientsJessica Selter, Yongmei Huang, Lisa C Grossman Becht, et al.
JNCI Cancer Spectrum|September 20, 2019
Quality of Care and Outcomes of Patients With Gynecologic Malignancies Treated at Safety-Net HospitalsCharlotte R Gamble, Yongmei Huang, Ana I Tergas, et al.
American Journal of Obstetrics and Gynecology|October 31, 2012
Feasibility and economic impact of same-day discharge for women who undergo laparoscopic hysterectomyMaria B Schiavone, Thomas J Herzog, Cande V Ananth, et al.
Molecular Pharmaceutics|September 9, 2011
Histone deacetylase inhibitors: emerging mechanisms of resistanceRobert W Robey, Arup R Chakraborty, Agnes Basseville, et al.
Cell Reports|February 12, 2013
Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinomaKrastan B Blagoev, Julia Wilkerson, Wilfred D Stein, et al.
Pageof 75